Journal article

Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells

Mercedes N Lopez, Cristian Pereda, Gabriela Segal, Leonel Munoz, Raquel Aguilera, Fermin E Gonzalez, Alejandro Escobar, Alexandra Ginesta, Diego Reyes, Rodrigo Gonzalez, Ariadna Mendoza-Naranjo, Milton Larrondo, Alvaro Compan, Carlos Ferrada, Flavio Salazar-Onfray

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2009

Grants

Awarded by Fund for the Promotion of Scientific and Technological Development


Awarded by National Fund for Scientific and Technological Development


Awarded by Millennium Nucleus on Immunology and Immunotherapy


Funding Acknowledgements

Supported by grants from the Fund for the Promotion of Scientific and Technological Development (FONDEF DO2I1088), the National Fund for Scientific and Technological Development (FONDECYT 1060935 and 1070559), Millennium Nucleus on Immunology and Immunotherapy P04/030-F.